share_log

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting

DELFI Diagnostics to Present at American Association for Cancer Research Annual Meeting

DELFI Diagnostics将在美国癌症研究协会年会上发表演讲
PR Newswire ·  04/01 21:00
DELFI Diagnostics, Inc. (PRNewsfoto/DELFI Diagnostics)
德尔菲诊断有限公司（PRNewsFoto/Delfi Diagnostics）
FirstLook Lung is a new blood test that offers a convenient, accessible, and personalized approach to enhance lung cancer screening. FirstLook helps determine the likelihood of detecting lung cancer through low-dose CT (LDCT), with a negative predictive value of 99.8%.
FirstLook Lung 是一项全新的血液检测，为加强肺癌筛查提供了一种方便、便捷和个性化的方法。FirstLook有助于确定通过低剂量CT（LDCT）检测出肺癌的可能性，阴性预测值为99.8％。

译文内容由第三方软件翻译。


以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。
    抢沙发